需紧急止血手术患者急诊科与手术室插管的比较
基于国家创伤数据库2017-2019年253个创伤中心9667例患者在到达后60分钟内接受止血手术的数据,排除到达即死亡、急诊开胸或有插管临床指征者后,比较急诊科插管与手术室插管。约20%患者在急诊科插管。风险调整后,急诊科插管与死亡率升高、急诊停留时间延长、输血量增加及重大并发症相关。医院层面分析显示,各中心急诊科插管倾向存在显著差异,高倾向医院的患者院内心脏骤停发生率更高(6% vs 4%;调整OR 1.46;95%CI 1.04-2.03)。作者认为,在可行时应推迟插管,优先快速复苏并转运至手术室。
要点
- 需紧急止血手术患者中,20%在急诊科插管;风险调整后与死亡率升高、急诊停留时间延长、输血量增加及重大并发症相关。
- 高急诊科插管倾向医院的患者院内心脏骤停发生率6% vs 低倾向医院4%,调整OR 1.46(95%CI 1.04-2.03)。
- 各创伤中心急诊科插管使用率存在显著差异,且不能由患者病例组合解释。
- 作者建议:在可行时推迟插管,优先快速复苏并转运至手术室。
- 证据等级:治疗/管理;Level III。
适用人群与场景
- 在1级或2级创伤中心到达后60分钟内接受止血手术的患者(国家创伤数据库2017-2019年)。
- 排除到达即死亡、接受急诊开胸术、或有插管临床指征(严重头/颈/面部损伤或格拉斯哥昏迷评分≤8分)的患者。
处置流程与药物剂量
- 作者建议:在可行时推迟插管,优先快速复苏并转运至手术室。
研究设计与关键结果
- 研究类型:基于国家创伤数据库2017-2019年的分析,纳入253个创伤中心9667例在到达后60分钟内接受止血手术的患者。
- 人群特征:以年轻男性为主(中位年龄33岁),穿透伤占71%;初始格拉斯哥昏迷评分中位数15分,收缩压中位数108 mm Hg。
- 20%的患者在急诊科插管。
- 风险调整后,急诊科插管与死亡率升高、急诊停留时间延长、输血量增加及重大并发症(心脏骤停、急性呼吸窘迫综合征、急性肾损伤、脓毒症)相关。
- 医院层面分析:各医院急诊科插管使用率存在显著差异,且不能由患者病例组合解释。
- 风险调整后,高急诊科插管倾向医院的患者与低倾向医院相比,院内心脏骤停发生率6% vs 4%,调整OR 1.46(95%CI 1.04-2.03)。
证据类型、等级与局限
- 证据类型:治疗/管理;证据等级Level III。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对需紧急止血手术的创伤患者,急诊科插管与不良结局相关,作者建议在可行时推迟插管,优先快速复苏并转运至手术室。
- 各中心急诊科插管使用率差异显著且不能由患者病例组合解释,提示该做法存在机构间变异。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Hemorrhage control surgery is an essential trauma center function. Airway management of the unstable bleeding patient in the emergency department (ED) presents a challenge. Premature intubation in the ED can exacerbate shock and precipitate extremis. We hypothesized that ED versus operating room intubation of patients requiring urgent hemorrhage control surgery is associated with adverse outcomes at the patient and hospital-levels.
METHODS: Patients who underwent hemorrhage control within 60 minutes of arrival at level 1 or 2 trauma centers were identified (National Trauma Data Bank 2017-2019). To minimize confounding, patients dead on arrival, undergoing ED thoracotomy, or with clinical indications for intubation (severe head/neck/face injury or Glasgow Coma Scale score of ≤8) were excluded. Two analytic approaches were used. First, hierarchical logistic regression measured the risk-adjusted association between ED intubation and mortality. Secondary outcomes included ED dwell time, units of blood transfused, and major complications (cardiac arrest, acute respiratory distress syndrome, acute kidney injury, sepsis). Second, a hospital-level analysis determined whether hospital tendency ED intubation was associated with adverse outcomes.
RESULTS: We identified 9,667 patients who underwent hemorrhage control surgery at 253 trauma centers. Patients were predominantly young men (median age, 33 years) who suffered penetrating injuries (71%). The median initial Glasgow Coma Scale and systolic blood pressure were 15 and 108 mm Hg, respectively. One in five (20%) of patients underwent ED intubation. After risk-adjustment, ED intubation was associated with significantly increased odds of mortality, longer ED dwell time, greater blood transfusion, and major complications. Hospital-level analysis identified significant variation in use of ED intubation between hospitals not explained by patient case mix. After risk adjustment, patients treated at hospitals with high tendency for ED intubation (compared with those with low tendency) were significantly more likely to suffer in-hospital cardiac arrest (6% vs. 4%; adjusted odds ratio, 1.46; 95% confidence interval, 1.04-2.03).
CONCLUSION: Emergency department intubation of patients who require urgent hemorrhage control surgery is associated with adverse outcomes. Significant variation in ED intubation exists between trauma centers not explained by patient characteristics. Where feasible, intubation should be deferred in favor of rapid resuscitation and transport to the operating room.
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level III.
参考来源
- Dunton Z, Seamon MJ, Subramanian M, et al. Emergency department versus operating room intubation of patients undergoing immediate hemorrhage control surgery. J Trauma Acute Care Surg. 2023. PMID: 36850033. doi:10.1097/TA.0000000000003907
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。